Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach

por Amjad, Fahd, Polenchar, Brett, Favit, Antonella
Publicado 2021

Characterization of the changes in supine blood pressure with long‐term use of droxidopa in patients with neurogenic orthostatic hypotension

por Hewitt, L. Arthur, Lindsten, Annika, Gorny, Stephen, Karnik‐Henry, Meghana, Kymes, Steven, Favit, Antonella
Publicado 2021

Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment

por Hauser, Robert A., Favit, Antonella, Hewitt, L. Arthur, Lindsten, Annika, Gorny, Stephen, Kymes, Steven, Isaacson, Stuart H.
Publicado 2022